CONNEQT Health has inked a marketing deal with US longevity platform Blueprint to boost consumer sales of its FDA-cleared Pulse arterial health monitor, targeting health-conscious Americans focused on preventative care.
- Marketing agreement with US longevity platform Blueprint
- CONNEQT Pulse promoted in Blueprint’s Protocol Marketplace
- Targets consumers focused on preventative cardiovascular health
- Supports CONNEQT’s evolving digital health and distribution strategy
Blueprint Partnership Opens New US Consumer Channel
CONNEQT Health (ASX:CQT) has taken a strategic step to broaden its US consumer footprint by partnering with Blueprint, a leading health platform specialising in longevity and preventative wellness. Under the newly signed marketing agreement, CONNEQT’s FDA-cleared Pulse Arterial Health Monitor will be featured prominently within Blueprint’s Protocol Marketplace, a curated online hub where products undergo rigorous clinical vetting before gaining certification.
This arrangement allows Blueprint to drive traffic through dedicated referral links, funneling customers directly to CONNEQT for purchases. By tapping into Blueprint’s community, comprised of consumers deeply engaged in health optimisation and longevity, CONNEQT gains access to a highly aligned audience, complementing its existing direct-to-consumer sales approach.
Strategic Fit with Preventative Health Ecosystems
CONNEQT’s CEO Craig Cooper emphasised the strategic rationale behind the deal, highlighting Blueprint’s reputation as a trusted platform built around evidence-based health solutions. “Blueprint has established a trusted community of consumers focused on evidence-based longevity and preventative health, making Blueprint a natural commercial partner for CONNEQT Pulse and our broader cardiovascular health platform,” Cooper said.
The partnership fits neatly within CONNEQT’s broader commercial evolution, which is moving beyond hardware sales into premium digital services, cardiology reporting, and cloud-based cardiovascular analytics. By embedding its product within a vetted marketplace, CONNEQT aims to enhance brand awareness and customer acquisition among health-conscious consumers who prioritise preventative cardiovascular care.
Blueprint’s Vetting Process Adds Credibility
Blueprint, founded by tech entrepreneur Bryan Johnson, is known for its stringent product certification process, overseen by a dedicated team of longevity researchers and doctors. Only products meeting high-quality clinical standards earn the Blueprint Certified seal, lending additional credibility to CONNEQT Pulse’s presence on the platform.
This certification requirement signals to consumers that CONNEQT’s arterial health monitor meets rigorous research benchmarks, potentially easing adoption hurdles in the competitive US wellness market. The partnership thus not only expands distribution but also reinforces CONNEQT’s positioning as a scientifically validated solution in the longevity space.
Commercial Model Evolves Amid Growth Initiatives
The Blueprint deal arrives as CONNEQT continues to scale its consumer revenue and enterprise subscriptions, following a recent surge in sales and capital raises to fund expansion. The company’s push towards cloud-based vascular analytics and premium digital offerings underscores a shift from device-centric sales to integrated health solutions.
While the announcement does not disclose financial terms or forecast sales impact, this partnership represents a meaningful channel expansion in a key market, potentially accelerating consumer uptake of CONNEQT Pulse. The collaboration also aligns with CONNEQT’s strategy to leverage trusted health ecosystems for growth, a move that could open doors to further partnerships and market penetration.
Bottom Line?
CONNEQT’s Blueprint partnership enhances US consumer access through a credible longevity platform, marking a tactical advance in its evolving digital health strategy.
Questions in the middle?
- How will sales via Blueprint compare to CONNEQT’s direct-to-consumer channels?
- Will Blueprint certification accelerate adoption among skeptical US consumers?
- Could this partnership pave the way for further collaborations in longevity ecosystems?